Fundies.
English

Trillium Therapeutics Inc.

EDGAR
TRIL Quarterly report (10-Q) · filed 2021-11-12

163 filing records in this dataset, filed from 2015-03-11 to 2021-11-12. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

10 thousand Unit_Standard_USD_sF43uLJqTU2MuIIbKvcjbQ

2021 Q2 · Unit_Standard_USD_sF43uLJqTU2MuIIbKvcjbQ

Exact inputs and evidence
  • Revenue: 10000 Unit_Standard_USD_sF43uLJqTU2MuIIbKvcjbQ Source
Cash and cash equivalents
93.2 million Unit_Standard_USD_hUBzAH1xX06AlCVB1Oas1Q Source
Exact value

93227000 Unit_Standard_USD_hUBzAH1xX06AlCVB1Oas1Q

Long-term debt including current maturities
Not available
Shares outstanding
105 million Unit_Standard_shares_kZKjSKhCgECNADpWIc6avw Source
Exact value

104995125 Unit_Standard_shares_kZKjSKhCgECNADpWIc6avw

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2021-11-12.

Financial data available through: 2020-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2020-12-31
  • Operating income: 2 of 11 periods available· newest 2020-12-31
  • Net income: 2 of 11 periods available· newest 2020-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2020-12-31
  • Capital expenditure: Multiple units; comparison withheld· newest 2019-12-31
  • Total assets: Multiple units; comparison withheld· newest 2020-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2020-12-31
  • Current assets: Multiple units; comparison withheld· newest 2020-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2020-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2020-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: Multiple units; comparison withheld· newest 2020-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -19.4%

    Prior period

    Unit12 124,000

    –

    Current period

    Unit12 100,000

    –

    Exact inputs and evidence

    100000 − 124000 = -24000 Unit12

    124000 Unit12 · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    100000 Unit12 · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −Unit12 21.26 million

    Prior period

    −Unit12 38.08 million

    –

    Current period

    −Unit12 59.35 million

    –

    Exact inputs and evidence

    -59346000 − -38082000 = -21264000 Unit12

    -38082000 Unit12 · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    -59346000 Unit12 · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit12 2.02 million

    Prior period

    −Unit12 24.75 million

    –

    Current period

    −Unit12 22.73 million

    –

    Exact inputs and evidence

    -22733000 − -24751000 = 2018000 Unit12

    -24751000 Unit12 · 2019-01-01 – 2019-12-31

    Inspect prior input Prior source

    -22733000 Unit12 · 2020-01-01 – 2020-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2020-01-01 – 2020-12-31

  • Revenue Unit12 100,000 100% of revenue
  • Operating costs Derived Unit12 61.56 million 61,555% of revenue
  • Operating income −Unit12 61.46 million −61,455% of revenue
  • Tax, interest and other Derived −Unit12 2.11 million −2,109% of revenue
  • Net income −Unit12 59.35 million −59,346% of revenue

Cash

  • Operating cash flow −Unit12 22.73 million −22,733% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2019 Operating loss: operating costs were 26,139% of revenue.
  • 2020 Operating loss: operating costs were 61,555% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2019 2019-01-01 – 2019-12-31124000 32412000 Derived -32288000 5794000 Derived -38082000 Unavailable
Source
2020 2020-01-01 – 2020-12-31100000 61555000 Derived -61455000 -2109000 Derived -59346000 Unavailable
Source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 100K 2020
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.133.9K100.4K67.0K33.5K0.020192020
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2019Revenue124000
2020Revenue100000

Revenue growth

Change in revenue from the same financial period one year earlier.

-19.4% 2020
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.5%-4.1%-9.7%-15.3%-20.9%20192020
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2019Year over yearNo prior comparable period
2020Year over year-19.4%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -61,455% 2020
Net margin -59,346% 2020
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4,916%-12,906%-30,727%-48,549%-66,371%20192020
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2019Operating margin-26,038.7%
2020Operating margin-61,455%
2019Net margin-30,711.3%
2020Net margin-59,346%
2019Free cash flow marginNot reported
2020Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 -22.7M 2020
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.0M-5.2M-12.4M-19.6M-26.7M20192020
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2019Operating cash flow-24751000
2020Operating cash flow-22733000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit12)Source evidence
2019Free cash flowUnavailable
2020Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2019-12-31Liabilities / assetsNot reportedNo source recorded
2020-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2019-12-31Current assets / current liabilitiesNot reportedNo source recorded
2020-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2019 2019-01-01 – 2019-12-31
−Unit12 38.08 million
Exact value

Exact value: -38082000 Unit12

2019-01-01 – 2019-12-31: -38082000 Unit12 Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit12 24.75 million
Exact value

Exact value: -24751000 Unit12

2019-01-01 – 2019-12-31: -24751000 Unit12 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2020 2020-01-01 – 2020-12-31
−Unit12 59.35 million
Exact value

Exact value: -59346000 Unit12

2020-01-01 – 2020-12-31: -59346000 Unit12 Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit12 22.73 million
Exact value

Exact value: -22733000 Unit12

2020-01-01 – 2020-12-31: -22733000 Unit12 Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

163 filings · 683 latest values · 683 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001616212, 1616212, TRIL, edgar:1616212, tril

Also known as TRILLIUM THERAPEUTICS INC., Trillium Therapeutics Inc.